Status:
COMPLETED
Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma
Lead Sponsor:
ARCAGY/ GINECO GROUP
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Oncology
Endometrial Cancer
Eligibility:
FEMALE
18-99 years
Brief Summary
This is a national observational retrospective multi-site chart review study of patients with advanced, recurrent or metastatic endometrial carcinoma.
Eligibility Criteria
Inclusion
- Adult women ≥ 18 years at index date.
- Documented diagnosis of advanced recurrent or metastatic endometrial cancer not eligible to primary complete surgery. Patients with interval surgery after primary CT may be eligible.
- Index date should represent at least the first\* or second line\*\* chemotherapy systemic treatment and occur between, 1, January 2019 and 31, December 2019.
- do not express refusal to her personal data processing or did not express her refusal for deceased patients.
Exclusion
- No clinical records for tumor imaging or administration of anti-cancer therapy.
- Patients with active malignancy other than EC cancer which contribute significantly to the clinical impairment of the patient during the study period, according to investigator opinion.
- Patients lost to follow-up, defined as patients whose last follow-up information occurs less than two years after index date (unless the patient is deceased).
- Patient did not receive chemotherapy systemic treatment.
- Patient undergo treatment by pembrolizumab or another immunotherapy in first line (cohort 1) or second line (cohort 2) during the eligibity (inclusion) period.
Key Trial Info
Start Date :
May 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 22 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05364905
Start Date
May 9 2022
End Date
November 22 2022
Last Update
September 6 2023
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Victor Dupouy
Argenteuil, France, 95100
2
Sainte-Catherine Institut du Cancer Avignon-Provence
Avignon, France, 84918
3
CHRU Besançon - Hôpital Jean Minjoz
Besançon, France, 25000
4
Guillaume BABIN
Bordeaux, France, 33000